233 related articles for article (PubMed ID: 31060263)
1. Targeted Therapy Against the Cell of Origin in Cutaneous Squamous Cell Carcinoma.
Goldie SJ; Chincarini G; Darido C
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060263
[TBL] [Abstract][Full Text] [Related]
2. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
[TBL] [Abstract][Full Text] [Related]
3. Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo.
Lotti R; Palazzo E; Petrachi T; Dallaglio K; Saltari A; Truzzi F; Quadri M; Puviani M; Maiorana A; Marconi A; Pincelli C
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771605
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma.
Liu S; Chen M; Li P; Wu Y; Chang C; Qiu Y; Cao L; Liu Z; Jia C
Cell Physiol Biochem; 2015; 36(2):499-508. PubMed ID: 25966742
[TBL] [Abstract][Full Text] [Related]
6. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
8. Identification of Human Cutaneous Squamous Cell Carcinoma Cancer Stem Cells.
Olivero C; Morgan H; Patel GK
Methods Mol Biol; 2019; 1879():415-433. PubMed ID: 29582375
[TBL] [Abstract][Full Text] [Related]
9. SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma.
Siegle JM; Basin A; Sastre-Perona A; Yonekubo Y; Brown J; Sennett R; Rendl M; Tsirigos A; Carucci JA; Schober M
Nat Commun; 2014 Jul; 5():4511. PubMed ID: 25077433
[TBL] [Abstract][Full Text] [Related]
10. Complement System in Cutaneous Squamous Cell Carcinoma.
Riihilä P; Nissinen L; Knuutila J; Rahmati Nezhad P; Viiklepp K; Kähäri VM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331124
[TBL] [Abstract][Full Text] [Related]
11. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
[TBL] [Abstract][Full Text] [Related]
12. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
[No Abstract] [Full Text] [Related]
13. Long-Lived Epidermal Cancer-Initiating Cells.
Youssef M; Cuddihy A; Darido C
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28654000
[TBL] [Abstract][Full Text] [Related]
14. Targeted next-generation sequencing of matched localized and metastatic primary high-risk SCCs identifies driver and co-occurring mutations and novel therapeutic targets.
Lobl MB; Clarey D; Higgins S; Sutton A; Hansen L; Wysong A
J Dermatol Sci; 2020 Jul; 99(1):30-43. PubMed ID: 32595073
[TBL] [Abstract][Full Text] [Related]
15. The Role of Epithelial-to-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma : Epithelial-to-Mesenchymal Transition in Cutaneous SCC.
Fernandez-Figueras MT; Puig L
Curr Treat Options Oncol; 2020 Apr; 21(6):47. PubMed ID: 32350682
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the cells of origin of squamous cell carcinomas.
Sánchez-Danés A; Blanpain C
Nat Rev Cancer; 2018 Sep; 18(9):549-561. PubMed ID: 29849070
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.
Schmitz S; Machiels JP
Curr Treat Options Oncol; 2016 Jul; 17(7):37. PubMed ID: 27262711
[TBL] [Abstract][Full Text] [Related]
18. PKC-δ attenuates the cancer stem cell among squamous cell carcinoma cells through down-regulating p63.
Zhang D; Fu M; Li L; Ye H; Song Z; Piao Y
Pathol Res Pract; 2017 Sep; 213(9):1119-1124. PubMed ID: 28756980
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
20. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling.
Schober M; Fuchs E
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10544-9. PubMed ID: 21670270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
